Back

High radiofrequency power for faster and safer pulmonary vein ablation trial (POWER FAST III)

4 April 2022 (18:45 - 18:55)
Organised by:
Congress Presentation Part of: Late Breaking Clinical Trials II - atrial fibrillation, news on ablation and sex differences Catheter Ablation of Arrhythmias EHRA Premium Access EHRA 2022

7 More presentations in this session

Presentation thumbnail
Sex differences in early rhythm control therapy in atrial fibrillation
Slides Video
Presentation thumbnail
Sex differences in early rhythm control therapy in atrial fibrillation - discussion.
Video
Presentation thumbnail
MANIFEST-PF: multi-national survey on methods, efficacy and safety on the post-approval clinical use of pulsed field ablation
Slides Video
Presentation thumbnail
MANIFEST-PF - discussion.
Video
Presentation thumbnail
POWER FAST III - discussion.
Video

Access the full session

Session thumbnail
Late Breaking Clinical Trials II - atrial fibrillation, news on ablation and sex differences
Video

The Event

Event poster

EHRA 2022

4 April 2022 18:45 CET
You may be interested in
thumbnail
Congress Presentation
POWER FAST III: clinical efficacy and safety
16 April 2023
thumbnail
Congress Presentation
BEAT PAROX AF: a randomized comparison of PFA vs RFA
31 August 2025
thumbnail
Congress Presentation
Impact of high-power and very high-power short-duration radiofrequency ablation on procedure characteristics and first-pass isolation during pulmonary vein isolation
29 August 2022
thumbnail
Congress Presentation
Optimized workflow with hybrid (very) high-power short-duration radiofrequency ablation renders point-by-point pulmonary vein isolation as fast and effective as cryoballoon ablation
31 March 2025

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources